Prevalence, comorbidities, and treatment patterns of patients with chronic spontaneous urticaria in Japan

Prevalence, comorbidities, and treatment patterns of patients with chronic spontaneous urticaria in Japan - Claim database study of chronic spontaneous urticaria in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051032

Enrollment

50000

Registered

2023-05-15

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic spontaneous urticaria

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study population consists of the patients diagnosed with urticaria in the JMDC Claims Database, in 2015 to 2021 for this study

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Annual prevalence of CSU is calculated by age and gender	—

Secondary

Measure	Time frame
Annual incidence rate of CSU is calculated by age and gender Comorbidities, HCRU, and current treatment for CSU	—

Countries

Japan

Contacts

Public ContactYuko KISHI

Sanofi K.K. Dermatology Medical, Immunology Medical, Specialty Care

Sanofi_Medical@sanofi.com03-6301-4575

Outcome results